Persistence of Resistant Staphylococcus epidermidis after Single Course of Clarithromycin

We examined how a common therapy that includes clarithromycin affects normally colonizing Staphylococcus epidermidis. Samples from the nostrils of 5 patients receiving therapy were collected before, immediately after, 1 year after, and 4 years after treatment. From each patient and sample, S. epider...

Full description

Bibliographic Details
Main Authors: Maria Sjölund, Eva Tano, Martin J. Blaser, Dan I. Andersson, Lars Engstrand
Format: Article
Language:English
Published: Centers for Disease Control and Prevention 2005-09-01
Series:Emerging Infectious Diseases
Subjects:
Online Access:https://wwwnc.cdc.gov/eid/article/11/9/05-0124_article
Description
Summary:We examined how a common therapy that includes clarithromycin affects normally colonizing Staphylococcus epidermidis. Samples from the nostrils of 5 patients receiving therapy were collected before, immediately after, 1 year after, and 4 years after treatment. From each patient and sample, S. epidermidis strains were isolated and analyzed for clarithromycin susceptibility and presence of the erm(C) gene. We show that macrolide-resistant strains of S. epidermidis were selected during therapy and that the same resistant strain may persist for 4 years, in the absence of further antimicrobial treatment.
ISSN:1080-6040
1080-6059